findmyKOL
Clinical trialNCT03399604CompletedPhase 3Interventional

Investigation of the Safety and Pharmacology of Dry Powder Inhalation of Treprostinil

SponsorLiquidia Technologies, Inc.Enrollment121Primary Pulmonary Hypertension
View the registry record on ClinicalTrials.gov

Summary

The registered summary isn't in our current data snapshot. Read it on the ClinicalTrials.gov record ↗. Why? →

Investigators

The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.

A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.

Sites

38 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.

United States
  • Arizona Pulmonary Specialists, Ltd.

    Phoenix, Arizona, United States

  • Banner University Medical Center

    Phoenix, Arizona, United States

  • West Los Angeles Va Healthcare Center

    Los Angeles, California, United States

  • Uc Davis Medical Center

    Sacramento, California, United States

  • Los Angeles Biomedical Research Center

    Torrance, California, United States

  • University of Colorado Anschutz Medical Campus

    Aurora, Colorado, United States

  • University of Florida

    Gainesville, Florida, United States

  • Mayo Clinic-Jacksonville

    Jacksonville, Florida, United States

  • Adventhealth

    Orlando, Florida, United States

  • Emory University School of Medicine

    Atlanta, Georgia, United States

  • Wellstar Research Institute

    Marietta, Georgia, United States

  • Northwestern Medicine, Feinberg School of Medicine

    Chicago, Illinois, United States

  • University of Chicago Medicine

    Chicago, Illinois, United States

  • University of Kansas Medical Center

    Kansas City, Kansas, United States

  • Kentuckiana Pulmonary Research Center

    Louisville, Kentucky, United States

  • Ochsner Medical Center

    New Orleans, Louisiana, United States

  • Tufts Medical Center

    Boston, Massachusetts, United States

  • University of Minnesota

    Minneapolis, Minnesota, United States

  • Mayo Clinic-Rochester

    Rochester, Minnesota, United States

  • Washington University School of Medicine

    St Louis, Missouri, United States

  • University of New Mexico Health Science Center

    Albuquerque, New Mexico, United States

  • Nyu Winthrop University Hospital

    Mineola, New York, United States

  • Nyu Langone Health

    New York, New York, United States

  • University of North Carolina School of Medicine

    Chapel Hill, North Carolina, United States

  • University of Cincinnati Medical Center

    Cincinnati, Ohio, United States

  • Cleveland Clinic

    Cleveland, Ohio, United States

  • University Hospitals of Cleveland Medical Center

    Cleveland, Ohio, United States

  • the Ohio State University Wexner Medical Center

    Columbus, Ohio, United States

  • Oregon Health and Science Center

    Portland, Oregon, United States

  • University of Pennsylvania Health System

    Philadelphia, Pennsylvania, United States

  • Alleghany General Hospital

    Pittsburgh, Pennsylvania, United States

  • Upmc Presbyterian Hospital

    Pittsburgh, Pennsylvania, United States

  • Ut Southwestern Medical Center

    Dallas, Texas, United States

  • Houston Methodist Lung Center

    Houston, Texas, United States

  • University of Texas - Health Science Center

    Houston, Texas, United States

  • University of Texas Health Science Center at San Antonio

    San Antonio, Texas, United States

  • Inova Fairfax Medical Campus

    Falls Church, Virginia, United States

  • the Medical College of Wisconsin/froedtert Hospital

    Milwaukee, Wisconsin, United States

Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.

Drugs studied

No drug or biological interventions are in our data for this study — it may test a procedure, device or behavioral intervention, or the intervention list isn't in our current snapshot. See the registry record ↗. Why? →

Registration & key dates

Registry attributes as recorded on the ClinicalTrials.gov study record.

Start
2 Jan 2018
Primary completion
6 May 2019
Completion
25 Nov 2019
Last update posted
30 Jul 2024
Registered enrollment
121
Registry id
NCT03399604

Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 12 Jul 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.